background image

Bladder Cancer Clinical Trials

Find clinical trials for bladder cancer. Search for bladder cancer clinical trials in different cities and states across the United States.

Filter
1
Active & ResponsiveNew

KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)

for
Bladder Cancer
Location: Salt Lake City UT
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07232602

Phase1, Phase2, Recruiting
Active & Responsive

Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT)

for
Bladder Cancer, Muscle-Invasive Bladder Carcinoma
Location: New York NY
Sponsor: Columbia University

Sex: All

Age: 18+

Code: NCT06571708

Phase2, Recruiting
Active & Responsive

Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit)

for
Bladder Cancer, Breast Cancer, Colon Cancer, Endometrial Cancer,
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 18+

Code: NCT05056077

Recruiting
Active & Responsive

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)

for
Non-Muscle Invasive Bladder Cancer
Location: Bakersfield CA, Tampa FL, Chicago IL, Baltimore MD,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06637423

Phase1, Phase2, Recruiting
Active & Responsive

Improving Care for Rural Patients With Solid Tumors

for
Lung Cancer, Head and Neck Cancer, Thyroid Cancer,
Location: Aurora CO, Colorado Springs CO, Fort Collins CO,
Sponsor: University of Colorado, Denver

Sex: All

Age: 18 - 70+

Code: NCT04916990

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

for
NSCLC Adenocarcinoma, Gastroesophageal Cancer (GC),
Location: Houston TX, Irving TX, Fairfax VA
Sponsor: IDEAYA Biosciences

Sex: All

Age: 18+

Code: NCT07277413

Phase1, Recruiting
Active & Responsive

Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

for
Localized Renal Pelvis and Ureter Urothelial Carcinoma,
Location: Seattle WA
Sponsor: University of Washington

Sex: Male

Age: 18+

Code: NCT01050504

Recruiting
Active & Responsive

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

for
Solid Tumor Malignancies, Colorectal Carcinoma,
Location: Denver CO, Orlando FL, Grand Rapids MI, St Louis MO,
Sponsor: Tasca Therapeutics

Sex: All

Age: 18+

Code: NCT07030257

Phase1, Phase2, Recruiting
Active & Responsive

Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy

for
Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma,
Location: Cleveland OH, Columbus OH
Sponsor: Yuanquan Yang

Sex: All

Age: 18+

Code: NCT06263153

Phase2, Recruiting
Active & Responsive

Mood Alterations in the Patients With Non-Muscle Invasive Bladder Cancer Treated With BCG

for
Non-Muscle Invasive Bladder Cancer
Location: Washington D.C. DC
Sponsor: Johns Hopkins University

Sex: All

Age: 18+

Code: NCT05672615

Recruiting